CTYPE html> ProCanBio | Biomarker Card

Biomarker Card

This biomarker card gives comprehensive information about each biomarker.
Detailed Information
Biomarker ID438
PMID19283074
Year2009
BiomarkerMethylation Status of: Chromosome 20 open reading frame 103 (C20orf103); Homeobox D9 (HOXD9); Nuclear receptor subfamily, group A, member 2 (NR5A2); Distal-less homeobox 5 (DLX5); Iroquois homeobox 1 (IRX1); Spastic paraplegia 20 (SPG20); Transcription factor AP-2 alpha (TFAP2A); Wilms tumor 1 (WT1); SIX homeobox 6 (SIX6); Homeobox D4 (HOXD4) ; Transcription factor 7-like 1 (TCF7L1); Sonic hedgehog homolog (SHH); Protocadherin, gamma subfamily C,5 (PCDHG5); Methionine aminopeptidase 1D (MAP1D); Runt-related transcription factor 1 (RUNX1)
Biomarker BasisMethylation Based
BiomoleculeMethylation
SourceTissue
SubjectsHumans
RegulationHypermethylated in PCa: [Chromosome 20 open reading frame 103 (C20orf103) (3.7 fold); Homeobox D9 (HOXD9) (3.2 fold); Nuclear receptor subfamily, group A, member 2 (NR5A2) (3.1 fold); Distal-less homeobox 5 (DLX5) (3.7 fold); Iroquois homeobox 1 (IRX1) (3.0 fold); Spastic paraplegia 20 (SPG20) (3.0 fold); Transcription factor AP-2 alpha (TFAP2A) (2.9 fold); Wilms tumor 1 (WT1) (2.9 fold); SIX homeobox 6 (SIX6) (2.8 fold); Homeobox D4 (HOXD4) (2.7 fold) ; Transcription factor 7-like 1 (TCF7L1) (2.6 fold); Sonic hedgehog homolog (SHH) (2.5 fold) ; Protocadherin , gamma subfamily C,5 (PCDHG5) (2.4 fold); Methionine aminopeptidase 1D (MAP1D) (2.3 fold); Runt-related transcription factor 1 (RUNX1) (2.3 fold);]
Odds Ratio/Hazard Ratio/Relative RiskNA
Effect on PathwaysNA
ExperimentCancer Vs Non Cancer
Type of BiomarkerDiagnostic
Cohort20 fresh frozen PCa tissue samples (10 Gleason score 6 or pure pattern 3 (PP3), and 10 Gleason score 8 or pure pattern 4. 39 PCa samples (20 PP3 and 19 PP4) from patients diagnosed were similarly collected for the validation set. The reference sample consisted of DNA isolated from lymphocytes of six healthy men age-matched with PCa patients.
SenstivityNA
SpecificityNA
AUCNA
AccuracyNA
Level Of Significancep<0.05
Method UsedCpG island arrays
ClinicalNo
RemarksNA
Clinical Trial NumberNA
Degree Of ValidityNot validated on independent patient dataset
Technical NameChromosome 20 open reading frame 103 (C20orf103), Homeobox D9 (HOXD9), Nuclear receptor subfamily, group A, member 2 (NR5A2), Distal-less homeobox 5 (DLX5), Iroquois homeobox 1 (IRX1), Spastic paraplegia 20 (SPG20), Transcription factor AP-2 alpha (TFAP2A), Wilms tumor 1 (WT1), SIX homeobox 6 (SIX6), Homeobox D4 (HOXD4), Transcription factor 7-like 1 (TCF7L1), Sonic hedgehog homolog (SHH), Protocadherin, gamma subfamily C,5 (PCDHG5), Methionine aminopeptidase 1D (MAP1D), Runt-related transcription factor 1 (RUNX1)